Killing pancreatic cancer with T cells that supercharge themselves
by University of California, San FranciscoTherapeutic T cells engineered with tumor-triggered IL-2 production infiltrate and clear immune-excluded tumors. (A) We hypothesized that cell autonomous
Updated on: February 18,2024
20
Killing pancreatic cancer with T cells that supercharge themselves
by University of California, San FranciscoTherapeutic T cells engineered with tumor-triggered IL-2 production infiltrate and clear immune-excluded tumors. (A) We hypothesized that cell autonomous
Updated on:February 18,2024
20
